Skip to content
healthcare.dev
Get a free key

Rivastigmine Tartrate

NDC 62756-145, Rivastigmine Tartrate, capsule, from Sun Pharmaceutical Industries, Inc..

Product NDC
62756-145
Status
Listed
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077131
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62756-145 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVASTIGMINE TARTRATE1.5 mg/1

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
62756-145-1362756014513500 CAPSULE in 1 BOTTLE (62756-145-13)
62756-145-6162756014561100 BLISTER PACK in 1 BOX, UNIT-DOSE (62756-145-61) / 1 CAPSULE in 1 BLISTER PACK
62756-145-866275601458660 CAPSULE in 1 BOTTLE (62756-145-86)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bac9ca81-db70-41aa-82af-6c5bb8496846

Use it

Look up 62756-145 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62756-145 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62756-145. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.